Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease

Katsutoshi Sato(Icahn School of Medicine at Mount Sinai), E. Premkumar Reddy(Icahn School of Medicine at Mount Sinai)
Nature Communications
August 3, 2021
Cited by 63


Related Papers